통합검색

한빛사

내가 찾은 검색어

1immune cell engineering

'immune cell engineering' 에 대한 통합검색결과 131건입니다.

한빛사131건

최신순
관련도순

- 김은혜(Virginia Tech)
- 이대용(Virginia Tech)
Engineering the physical characteristics of biomaterials for innate immune-mediated cancer immunotherapy
- J. Control. Release Dec 30 2024, 378 S0168-3659(24)00901-5 | https://doi.org/10.1016/j.jconrel.2024.12.046
- 2024.12
- 바이오·의료융합
Neoantigen-Displaying Protein Nanoparticles as a Therapeutic Cancer Vaccine Against Melanoma
- Adv. Healthc. Mater. Dec 23 2024, | https://doi.org/10.1002/adhm.202404316
- 2024.12
- 바이오·의료융합
- 강성훈(University of Chicago)
Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunothera
- J. Immunother. Cancer Dec 22 2024, 12 (12) e009541 | https://doi.org/10.1136/jitc-2024-009541
- 2024.12
- 바이오·의료융합
Tailoring osteoimmunity and hemostasis using 3D-Printed nano-photocatalytic bactericidal scaffold for augmented bone regeneration
- Biomaterials Dec 06 2024, 316 S0142-9612(24)00526-X | https://doi.org/10.1016/j.biomaterials.2024.122991
- 2024.12
- 바이오·의료융합
- 한준수(University of Illinois at Urbana Champaign)
Cytokine-overexpressing dendritic cells for cancer immunotherapy
- Exp. Mol. Med. 02 December 2024 | https://doi.org/10.1038/s12276-024-01353-5
- 2024.12
- 생명과학
- Xuan Zou(KAIST, Shenzhen University)
- 이상엽(KAIST)
Overcoming Bacteriophage Contamination in Bioprocessing: Strategies and Applications
- Small Methods Oct 02 2024, | https://doi.org/10.1002/smtd.202400932
- 2024.10
- 생명과학
- 장성민(California Institute of Technology)
Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder
- Nat. Commun. 08 September 2024 | https://doi.org/10.1038/s41467-024-52149-0
- 2024.09
Adipose-derived stem cell-based anti-inflammatory paracrine factor regulation for the treatment of inflammatory bowel disease
- J. Control. Release Aug 23 2024, 374 S0168-3659(24)00574-1 | https://doi.org/10.1016/j.jconrel.2024.08.027
- 2024.08
- 바이오·의료융합
Electrical Stimulating Redox Membrane Incorporated with PVA/Gelatin Nanofiber for Diabetic Wound Healing
- Adv. Healthc. Mater. Jul 11 2024, | https://doi.org/10.1002/adhm.202400170
- 2024.07
- 바이오·의료융합
- 정영록(Tessa Therapeutic)
Overexpression of an Engineered SerpinB9 Enhances Allogeneic T-Cell Persistence and Efficacy
- Cancer Immunol. Res. 2024 Jun 4 | https://doi.org/10.1158/2326-6066.CIR-23-1001
- 2024.06
- 김성웅(Cornell University)
Functionalized nanowires for miRNA-mediated therapeutic programming of na?ve T cells
- Nat. Nanotechnol. 29 April 2024 | https://doi.org/10.1038/s41565-024-01649-7
- 2024.04
- 생명과학
이대용

University of Texas MD Anderson Cancer Center

세포 내 DNA 센서는 이중 가닥 DNA나 순환 뉴클레오타이드와 같은 천연 작용제에 의해 활성화되어 항원 제시 세포(APCs)에서 선천 면역을 조절하고 후천 면역 반응을 유도할 수 있습니다. 그러나 세포 내 전달, 혈청 안정성, 효소적 분해 등의 문제로 인해 이러한 센서의 활성화는 어려움을 겪고 있습니다. 본 연구에서는 나선 모양 폴리펩타이드의 특성이 APCs에서 천연 면역 경로를 자극할 수 있다는 것이 밝혔습니다.
- Nat. Biomed. Eng.
- 2024.04.24
Immortalized nanodendritic cells decorated with immune-checkpoint inhibitors for personalized cancer immunotherapy
- Nano Today Available online 27 March 2024 | https://doi.org/10.1016/j.nantod.2024.102237
- 2024.03
- 생명과학
Artificial Vasa-Vasorum Serves as an On-Site Regenerative Promoter of Cell-Free Vascular Grafting
- Adv. Funct. Mater. 10 March 2024 | https://doi.org/10.1002/adfm.202315310
- 2024.03
- 바이오·의료융합
- 박상우(Cornell University, 현 Harvard Medical School / Massachusetts General Hospital)
  Interview
Immunoengineering can overcome the glycocalyx armour of cancer cells
- Nat. Mater. Published: 15 February 2024 | https://doi.org/10.1038/s41563-024-01808-0
- 2024.02
- 생명과학
- Amal George Kurian(단국대학교)
- 김해원(단국대학교 조직재생공학연구원/치과대학)
Nanozyme-Engineered Hydrogels for Anti-Inflammation and Skin Regeneration
- Nano-Micro Lett. Feb 06 2024, 16 (1) 110 | https://doi.org/10.1007/s40820-024-01323-6
- 2024.02
- 의약학
최재혁

Northwestern University

Adoptive T cell therapies have produced spectacular results in multiple treatment-related diseases. However, they have failed to make a significant impact on solid tumors, which represent >90% of all adult cancers. Solid tumors have an immunosuppressive microenvironment that limits T cell persistence and potency. To overcome this barrier and address the important clinical unmet need, we turned to extranodal T cell lymphomas, which develop mutations that increase T cell fitness in analogous microenvironments.
- Nature
- 2024.02.20
이효형

서울대학교, Icahn School of Medicine at Mount Sinai

Psoriasis is a chronic, T-cell-mediated inflammatory skin disease with a Th17-skewed immune phenotype. Regulatory T cells (Tregs) play a key role in suppressing the inflammatory immune response and inducing immune homeostasis and self-tolerance. While the role of Tregs in the pathogenesis of psoriasis has been proposed, the exact mechanisms of action and the molecular characterization of skin-homing psoriatic Tregs has not yet been well explored.
- EBioMedicine
- 2024.02.16
Protein cage nanoparticle-based NK cell-engaging nanodrones (NKeNDs) effectively recruit NK cells to target tumor sites and suppress tumor growth
- Nano Today Available online 2 December 2023 | https://doi.org/10.1016/j.nantod.2023.102075
- 2023.12
- 생명과학
Surface Engineering of Natural Killer Cells with CD44-targeting Ligands for Augmented Cancer Immunotherapy
- Small Dec 31 2023, | https://doi.org/10.1002/smll.202306738
- 2023.12
- 생명과학